N/A
N=86
Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients
Adolescent · Young Adult · Cancer
Bottom Line
View on ClinicalTrials.gov: NCT04448678 ↗Enrolled (actual)
86
Serious AEs
—
Results posted
Jan 2024
Primary outcome: Primary: Feasibility Measurement — 39; 25 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Health Insurance Education Program (HIEP) (Behavioral); Usual Care (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Utah
- Primary completion
- Sep 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility Measurement |
39; 25 | — |
| PRIMARY Acceptability - Module Satisfaction |
10; 0 | — |
| PRIMARY Navigator Satisfaction |
30.84; 30.32 | — |
| SECONDARY Changes in Efficacy- Health Insurance Literacy |
5.39; 2.30; 3.84 | 0.0401 sig |
| SECONDARY Changes in Efficacy- Affordable Care Act (ACA) Familiarity |
5.84; 2.03; 3.93 | 0.0049 sig |
| SECONDARY Changes in Efficacy-Financial Distress |
3.70; 2.89; 3.32; 3.08; 0.741; 1.87 | 0.297 |
Summary
This is a test of an existing health insurance education program (HIEP) in adolescent and young adult (AYA) individuals (aged 18-39) diagnosed with cancer. The study will evaluate whether the HIEP delivered by patient navigators improves participants' health insurance and cost-related literacy compared to usual navigation care, which does not include education on insurance and medical costs. The study team hypothesizes that: The HIEP will improve participants' health insurance and cost-related literacy compared to usual navigation care. Specifically, that participants in the intervention arm will report greater 1) health insurance and cost literacy, including confidence with provider communication about costs, 2) familiarity with ACA policies, and 3) improvement in financial distress related to medical costs. Participants will fill out a survey upon enrollment and a follow up survey 3 months after meeting with a patient navigator where they may or may not receive the HIEP.
Eligibility Criteria
Inclusion Criteria
- Were diagnosed with cancer between the ages of 18 and 39 AND
- Are within 1 year of a cancer diagnosis AND
- Are actively receiving chemotherapy, surgery, radiation, and/or hormonal therapy AND
- Are currently insured AND
- A patient at Primary Children's Hospital, Intermountain Medical Center or Huntsman Cancer Institute AND
- Speak English AND
- Have access to an electronic device compatible with video conferencing (e.g., smartphone, laptop, etc.).
Exclusion Criteria
- Are unable to participate due to developmental delay OR
- Speak a language other than English OR
- Are currently uninsured OR
- Do not have access to an electronic device compatible with video conferencing (e.g., smartphone, laptop, etc.).
Data sourced from ClinicalTrials.gov (NCT04448678). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.